Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,682
Total Claims
$1.2M
Drug Cost
1,194
Beneficiaries
$1,004
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-43%
Opioid rate vs peers
1.5% vs 2.6% avg
-6%
Cost per patient vs peers
$1,004 vs $1,068 avg
-2%
Brand preference vs peers
8.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.5%
Opioid Rate
259
Opioid Claims
$2,997
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,544 claims · $911K
Generic: 16,032 claims · $281K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 129 | $131K |
| Semaglutide | 71 | $79K |
| Insulin Lispro | 18 | $56K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $54K |
| Empagliflozin | 37 | $51K |
| Insulin Detemir | 28 | $39K |
| Dulaglutide | 30 | $37K |
| Insulin Aspart | 24 | $26K |
| Sitagliptin Phosphate | 20 | $20K |
| Fluticasone Propion/Salmeterol | 17 | $18K |
| Insulin Glargine/Lixisenatide | 11 | $17K |
| Fluticasone Propion/Salmeterol | 55 | $17K |
| Budesonide/Formoterol Fumarate | 22 | $17K |
| Tiotropium Bromide | 18 | $16K |
| Insulin Degludec | 27 | $16K |
Prescribing Profile
Patient Profile
73
Avg Age
47%
Female
1.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data